Amneal Pharmaceuticals

AMRX66

$8.46arrow_drop_down2.70%-$0.23

AMRX66

$8.46

arrow_drop_down2.70%-$0.23

Performance History

Key Stats
Open	$8.69
Prev. Close	$8.70
EPS	-0.79
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	8.49	8.72
52 Week Range	3.36	8.94

Ratios







EPS	-0.79

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Inc. (AMRX) is a global generic pharmaceutical company that develops, manufactures, and distributes high-quality generic pharmaceuticals. With a commitment to improving the health and well-being of patients, Amneal focuses on providing cost-effective treatments across a wide range of therapeutic areas.

The stock price history of Amneal Pharmaceuticals Inc. (AMRX) reflects the company's growth and performance over time. Investors can track the historical prices of AMRX stock to analyze trends and make informed investment decisions.

To get the latest quote for Amneal Pharmaceuticals Inc. (AMRX) stock, investors can refer to reliable financial sources. The stock quote provides information about the current market price of AMRX and any changes in its value.

Staying updated with the latest news related to Amneal Pharmaceuticals Inc. (AMRX) is crucial for investors. News articles and press releases often cover important developments, such as product launches, partnerships, regulatory approvals, and financial results, which can impact the stock price and investor sentiment.

Analyzing Amneal Pharmaceuticals Inc. (AMRX) stock involves assessing various factors, including financial performance, market trends, competitive landscape, and industry outlook. Investors can use different analytical tools and methodologies to gain insights into the company's prospects and determine its investment potential.

Smart analysis of Amneal Pharmaceuticals Inc. (AMRX) involves leveraging sophisticated algorithms and data analysis techniques to make intelligent investment decisions. By analyzing historical data, market trends, and other relevant variables, smart analysis aims to provide accurate predictions and optimize investment strategies for AMRX stock.

The market capitalization, or market cap, of Amneal Pharmaceuticals Inc. (AMRX) represents the total value of the company's outstanding shares. It is calculated by multiplying the current share price by the total number of shares outstanding. The market cap reflects the company's overall worth in the stock market and is an important metric for investors to consider.

The price-to-earnings growth (PEG) ratio of Amneal Pharmaceuticals Inc. (AMRX) is a valuation metric that takes into account earnings growth. It is calculated by dividing the price-to-earnings (P/E) ratio by the projected earnings growth rate. The PEG ratio provides a more comprehensive view of a stock's valuation by considering both earnings and growth potential.

Comparing Amneal Pharmaceuticals Inc. (AMRX) to its industry peers can provide valuable insights for investors. Industry analysis helps investors understand how AMRX performs relative to its competitors in terms of financial metrics, market share, product portfolio, and other key factors.

The 52-week range of Amneal Pharmaceuticals Inc. (AMRX) indicates the lowest and highest prices at which the stock has traded over the past year. Investors can use this range to assess the stock's volatility and determine potential buying or selling opportunities.

The day range of Amneal Pharmaceuticals Inc. (AMRX) provides information about the lowest and highest prices at which the stock is trading during a particular trading session. It helps investors gauge the intraday fluctuations in the stock price.

The trading volume of Amneal Pharmaceuticals Inc. (AMRX) represents the total number of shares that are bought and sold during a given period. Higher trading volumes indicate increased investor interest and can impact the liquidity of the stock.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Chirag K. Patel
Headquarters: Bridgewater
Employees: 7600
Exchange: NYSE

Keep an eye on Amneal Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Amneal Pharmaceuticals 's (AMRX) price per share?

The current price per share for Amneal Pharmaceuticals (AMRX) is $8.46. The stock has seen a price change of -$0.23 recently, indicating a -2.7% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Amneal Pharmaceuticals (AMRX)?

For Amneal Pharmaceuticals (AMRX), the 52-week high is $8.94, which is 5.67% from the current price. The 52-week low is $3.36, the current price is 151.79% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Amneal Pharmaceuticals (AMRX) a growth stock?

Amneal Pharmaceuticals (AMRX) has shown an average price growth of -1.93% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amneal Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Amneal Pharmaceuticals (AMRX) stock price performance year to date (YTD)?

As of the latest data, Amneal Pharmaceuticals (AMRX) has a year-to-date price change of 41.47%. Over the past month, the stock has experienced a price change of -3.64%. Over the last three months, the change has been 11.32%. Over the past six months, the figure is 55.23%. Looking at a longer horizon, the five-year price change stands at 191.72%.

help

Is Amneal Pharmaceuticals (AMRX) a profitable company?

Amneal Pharmaceuticals (AMRX) has a net income of -$48.72M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 34.28% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.74% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.39B, with a revenue growth rate of 8.2%, providing insight into the company's sales performance and growth. The gross profit is $820.56M. Operating income is noted at $204.37M. Furthermore, the EBITDA is $472.06M.

help

What is the market capitalization of Amneal Pharmaceuticals (AMRX)?

Amneal Pharmaceuticals (AMRX) has a market capitalization of $2.62B. The average daily trading volume is 8.51, indicating the stock's liquidity and investor engagement.

News

Opioid Overdose Treatment Market is Projected to Reach US$ 3.1 Billion by 2034 | Fact.MR Report

AMPHASTAR PHARMACEUTICALS

AMNEAL PHARMACEUTICALS

Sep 6, 2024

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

SOLID ORGAN TRANSPLANT

Solid Organ Transplant Market is Projected to Grow at a 4.9% CAGR, Reaching $7.88 Billion by 2034 | Fact.MR Report

PERICARDITIS

CARDIAC DISORDERS

ANTI-INFLAMMATORY DRUGS

GENERICS

Aug 16, 2024

Pericarditis Drugs Global Strategic Business Report 2023-2030: Patent Expiries and Surge of Generics in the Market, Increasing Incidence of Cardiac Disorders Driving Demand